Use of beta-blockers in obesity hypertension: potential role of weight gain.
about
Sympathetic nervous system overactivity and its role in the development of cardiovascular diseaseMetoprolol compared to carvedilol deteriorates insulin-stimulated endothelial function in patients with type 2 diabetes - a randomized study.Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.Hypertension--a treatable component of the cardiometabolic syndrome: challenges for the primary care physician.Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.Changes in lifestyle after hypertension diagnosis in Canada.Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies.Mechanisms of obesity-induced hypertension.The role of Beta-blockers as first-line therapy in hypertension.Nebivolol for the treatment of heart failure.Perivascular adipose tissue as a regulator of vascular disease pathogenesis: identifying novel therapeutic targets.[High blood pressure in obese children and adolescents].Obesity in Women: Insights for the Clinician.Beta3-adrenoceptor function and long-term changes in body weight.Blocking β₁/β₂-Adrenergic Signaling Reduces Dietary Fat Absorption by Suppressing Expression of Pancreatic Lipase in High Fat-Fed Mice.Energy metabolism in BPH/2J genetically hypertensive mice.2007 ESH‐ESC Guidelines for the management of arterial hypertension
P2860
Q28279754-AB59027E-EB4E-49BA-B08E-EF1BCBAFC31BQ33945028-FA8605FF-197A-459C-B8F7-2AC13687CB3AQ35958750-AA015ABE-D2BF-42F7-880A-558412F88322Q36369676-D8C44651-EB38-45AF-A9CF-22E7DFD282F2Q37098549-2237E75D-3691-4A6E-A0ED-0CFF979F3187Q37113375-042DBF19-7C28-45AC-9736-34B2CDE59617Q37592881-8AC56D6F-915C-46BA-8F34-B251C515E01EQ37742440-F81BD837-F71C-439F-8D3E-BE2F5531113BQ37826118-F90EB27B-C22F-4B59-989D-06E1CEABE3CCQ37943377-2D6536F9-7367-4D7E-8788-08598939608FQ39038872-B86CF570-A217-47B0-ABF1-F6DB4328BFA4Q45417473-DCD04169-18CA-4274-BCE6-056A3104DDDAQ46301919-65F0A470-4F59-4A0B-AFD3-AFDAD1ADA449Q47188169-05B2DEBB-7257-4D9D-A646-B9BEEC6E8F1FQ53079144-D8B0DE48-B3AA-427D-9A29-2C79B87C5253Q54490216-041E656F-E399-44F5-A565-9DFC5AE4C7AFQ56970799-593088E2-1287-47A4-AA03-1CA9E18AEBEE
P2860
Use of beta-blockers in obesity hypertension: potential role of weight gain.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
name
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@ast
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@en
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@nl
type
label
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@ast
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@en
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@nl
prefLabel
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@ast
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@en
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@nl
P2860
P921
P1433
P1476
Use of beta-blockers in obesity hypertension: potential role of weight gain.
@en
P2093
P2860
P304
P356
10.1046/J.1467-789X.2001.00044.X
P577
2001-11-01T00:00:00Z